ConductScience.org, home

Paper4039488

Comparison of the cytotoxic activities of chemotherapeutic drugs using a human bladder cancer cell line.

Hepburn PJ and 4 others. Urol Res, 1985. Cited by 13 papers, by iCite.

Cite this record

ConductScience Library. Comparison of the cytotoxic activities of chemotherapeutic drugs using a human bladder cancer cell line. Papers, record 4039488. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/4039488

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Comparison of the cytotoxic activities of chemotherapeutic drugs using a human bladder cancer cell line.
PubMed
Journal
Urol Res
PubMed
Year
1985
PubMed
Publication types
Comparative Study, Journal Article
PubMed
Citations, by iCite
13
iCite
Relative citation ratio, by iCite
0.81
iCite
Revised in PubMed
2026-10-10
PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Hepburn PJP J
2Oliver RTR T
3Riley PAP A
4Hill BTB T
5Masters JRJ R

Source PubMed

Download CSV of authors

Topics13

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antineoplastic AgentsMajor topic
Carcinoma, Transitional CellMajor topic
Colony-Forming Units AssayMajor topic
Tumor Stem Cell AssayMajor topic
Urinary Bladder NeoplasmsMajor topic
Animals
Cell Line
Dose-Response Relationship, Drug
Drug Evaluation, Preclinical
Humans
Mice
Mice, Nude
Neoplasm Transplantation

Source PubMed

Download CSV of topics

References41

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
1538695New assay for cytotoxic agents in human bladder cancer.Surg Forum1979https://conductscience.org/library/papers/538695PubMed
35127083Methotrexate pharmacokinetics.J Pharm Sci1971https://conductscience.org/library/papers/5127083PubMed
47340985A comparative assessment of the in vitro effects of drugs on cells by means of colony assays or flow microfluorimetry.Cancer Chemother Pharmacol1981https://conductscience.org/library/papers/7340985PubMed
57267186Assessments of the sensitivities of cultured human neuroblastoma cells to anti-tumour drugs.Pediatr Res1981https://conductscience.org/library/papers/7267186PubMed
67189443Chemotherapy of metastatic bladder cancer.Cancer1980https://conductscience.org/library/papers/7189443PubMed
77349890Comparison of pharmacokinetics of 5-fluorouracil and 5-fluorouracil with concurrent thymidine infusions in a Phase I trial.Cancer Res1980https://conductscience.org/library/papers/7349890PubMed
8421720Patterns of cell survival following treatment with antitumor agents in vitro.Eur J Cancer (1965)1979https://conductscience.org/library/papers/421720PubMed
96230463Methotrexate in the treatment of metastatic and recurrent primary transitional cell carcinoma.J Urol1984https://conductscience.org/library/papers/6230463PubMed
106189661Clinical pharmacokinetics of commonly used anticancer drugs.Clin Pharmacokinet1983https://conductscience.org/library/papers/6189661PubMed
117208525Tabular summary of pharmacokinetic parameters relevant to in vitro drug assay.Prog Clin Biol Res1980https://conductscience.org/library/papers/7208525PubMed
126840436Chemosensitivity of established human bladder carcinoma cell lines in vitro.Gan1983https://conductscience.org/library/papers/6840436PubMed
1386392Bleomycin pharmacokinetics in man. I. Intravenous administration.Cancer Chemother Pharmacol1978https://conductscience.org/library/papers/86392PubMed
146891658Metabolism and pharmacokinetics of dibromodulcitol (DBD, NSC-104800) in man--II. pharmacokinetics of DBD.Eur J Cancer Clin Oncol1982https://conductscience.org/library/papers/6891658PubMed
15856462Plasma pharmacokinetics of adriamycin and its metabolites in humans with normal hepatic and renal function.Cancer Res1977https://conductscience.org/library/papers/856462PubMed
165042371The absorption and metabolism of dibromodulcitol in patients with advanced cancer.Clin Pharmacol Ther1972https://conductscience.org/library/papers/5042371PubMed
176347376Mitoxantrone (novantrone): a review of experimental and early clinical studies.Cancer Treat Rev1983https://conductscience.org/library/papers/6347376PubMed
185912615Comparison of the sensitivity of normal hematopoietic and transplanted lymphoma colony-forming cells to chemotherapeutic agents administered in vivo.J Natl Cancer Inst1966https://conductscience.org/library/papers/5912615PubMed
197127334Etoposide--chemistry, preclinical and clinical pharmacology.Cancer Treat Rev1982https://conductscience.org/library/papers/7127334PubMed
206761010Early clinical studies with cis-diammine-1,1-cyclobutane dicarboxylate platinum II.Cancer Chemother Pharmacol1982https://conductscience.org/library/papers/6761010PubMed
216850648Plasma pharmacokinetics of adriamycin and adriamycinol: implications for the design of in vitro experiments and treatment protocols.Cancer Res1983https://conductscience.org/library/papers/6850648PubMed

See all 41 referencesDownload CSV of references

Cited by4

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 13 citations.

PMIDTitleJournalYearIn PapersSource
3730251Human bladder cancer in vitro drug sensitivities: range and stability in long-term culture.Br J Cancer1986https://conductscience.org/library/papers/3730251PubMed
3103302Intravesical chemotherapy: combination with Tween 80 increases cytotoxicity in vitro.Urol Res1987https://conductscience.org/library/papers/3103302PubMed
3103301Antineoplastic drug cytotoxicity in a human bladder cancer cell line: implications for intravesical chemotherapy.Urol Res1987https://conductscience.org/library/papers/3103301PubMed
3092427Intravesical chemotherapy: in vitro studies on the relationship between dose and cytotoxicity.Urol Res1986https://conductscience.org/library/papers/3092427PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/4039488

GET https://conductscience.org/api/papers/v1/4039488/references?page=2